- Home
- BNRG vs BDRX Comparison
BNRG vs BDRX Comparison
Compare BNRG & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.21
Company Overview
Basic Information| Metric | BNRG | BDRX |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNRG | BDRX |
|---|---|---|
| Price | $1.83 | $1.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 146.5K | ★ 517.1K |
| Earning Date | 02-27-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $387,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 843.90 | N/A |
| 52 Week Low | $2.19 | $1.22 |
| 52 Week High | $60.55 | $92.00 |
Technical Indicators
Market Signals| Indicator | BNRG | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.46 | 28.35 |
| Support Level | $2.19 | $1.22 |
| Resistance Level | $2.84 | $1.38 |
| Average True Range (ATR) | 0.46 | 0.14 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 35.97 | 0.93 |
Price Performance
Historical Comparison BNRG
BDRX
About BNRG Brenmiller Energy Ltd
Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.